GB201009801D0 - Compounds 950 - Google Patents

Compounds 950

Info

Publication number
GB201009801D0
GB201009801D0 GBGB1009801.0A GB201009801A GB201009801D0 GB 201009801 D0 GB201009801 D0 GB 201009801D0 GB 201009801 A GB201009801 A GB 201009801A GB 201009801 D0 GB201009801 D0 GB 201009801D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1009801.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB1009801.0A priority Critical patent/GB201009801D0/en
Publication of GB201009801D0 publication Critical patent/GB201009801D0/en
Application status is Ceased legal-status Critical

Links

GBGB1009801.0A 2010-06-11 2010-06-11 Compounds 950 Ceased GB201009801D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1009801.0A GB201009801D0 (en) 2010-06-11 2010-06-11 Compounds 950

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1009801.0A GB201009801D0 (en) 2010-06-11 2010-06-11 Compounds 950
PCT/GB2010/052111 WO2011154678A1 (en) 2010-06-11 2010-12-16 Compounds

Publications (1)

Publication Number Publication Date
GB201009801D0 true GB201009801D0 (en) 2010-07-21

Family

ID=42471510

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1009801.0A Ceased GB201009801D0 (en) 2010-06-11 2010-06-11 Compounds 950

Country Status (2)

Country Link
GB (1) GB201009801D0 (en)
WO (1) WO2011154678A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3192B1 (en) 2011-09-06 2018-03-08 Novartis Ag Benzothiazolone compound

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
SI0880508T1 (en) 1996-02-13 2003-10-31 Astrazeneca Ab Quinazoline derivatives as vegf inhibitors
DK0885198T3 (en) 1996-03-05 2002-03-25 Astrazeneca Ab 4-anilinoquinazoline derivatives
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
CA2406979A1 (en) 2000-05-31 2001-12-06 Astrazeneca Ab Indole derivatives with vascular damaging activity
CN1255392C (en) 2000-07-07 2006-05-10 安吉奥金尼药品有限公司 Colchinol derivatives as angiogenesis inhibitors
EP1301497A1 (en) 2000-07-07 2003-04-16 Angiogene Pharmaceuticals Limited Colchinol derivatives as vascular damaging agents
TW200531692A (en) 2004-01-12 2005-10-01 Theravance Inc Aryl aniline derivatives as β2 adrenergic receptor agonists
US20050215542A1 (en) 2004-03-23 2005-09-29 Pfizer Inc Compounds for the treatment of diseases
WO2005092841A1 (en) 2004-03-23 2005-10-06 Pfizer Limited Compounds having beta-agonist activity
EP1833822A2 (en) 2004-08-16 2007-09-19 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TWI374883B (en) 2004-08-16 2012-10-21 Theravance Inc Crystalline form of a biphenyl compound
DE102004045648A1 (en) 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg New betamimetics for the treatment of respiratory diseases
WO2006051373A1 (en) 2004-11-12 2006-05-18 Pfizer Limited Compounds for the treatment of diseases
GB0428111D0 (en) 2004-12-22 2005-01-26 Kudos Pharm Ltd Pthalazinone derivatives
DE102005007654A1 (en) 2005-02-19 2006-08-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting beta-mimetics for the treatment of respiratory diseases
TW200740781A (en) 2005-08-29 2007-11-01 Astrazeneca Ab Novel compounds
TW200811105A (en) 2006-04-25 2008-03-01 Theravance Inc Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
WO2008149110A1 (en) 2007-06-08 2008-12-11 Argenta Discovery Limited Bicyclor [2.2.1] hept-7-ylamine derivatives and their use in the treatment of diseases and conditions in which m3 muscarinic receptor activity and beta-adrenergic activity are implicated

Also Published As

Publication number Publication date
WO2011154678A1 (en) 2011-12-15

Similar Documents

Publication Publication Date Title
EP2566479A4 (en) Azaindazoles
GB201112931D0 (en) Metail 3
AP3107A (en) 5-Alkynyl-pyrimidines
GB201215746D0 (en) Rotocraft
GB201007286D0 (en) New compounds
TWI525071B (en) Novel compound
IL223783D0 (en) Pro-neurogenic compounds
HK1171452A1 (en) Substituted pyrrolidine-2-carboxamides -2-
GB201008134D0 (en) Compounds
GB201020179D0 (en) New compounds
GB201005589D0 (en) Novel compounds
IL238396D0 (en) אינגנול–3–אצילאטים iii ואינגנול–3–קרבמאטים
TWI541243B (en) Substituted imidazopyridazines
GB201015949D0 (en) Compounds
EP2640189A4 (en) 3-deutero-pomalidomide
TWI516264B (en) Aroylquinoline compounds
HRP20181800T1 (en) Well
ZA201108962B (en) Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750
IL221901D0 (en) Morpholinylquinazolines
TWI541244B (en) Imidazotriazinone compounds
GB201007203D0 (en) Novel compounds
AP3391A (en) 2-Amino-4-arylthiazole compounds as TROA1 antagonists
HK1179966A1 (en) Tetrahydro-pyrido-pyrimidine derivatives --
SI2569319T1 (en) Heteroaryl-cyclohexyl-tetraazabenzošećazulenes
GB201112400D0 (en) No details

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)